Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

177Lu-PSMA-I&T for Metastatic Castration-Resistant Prostate Cancer

ClinicalTrials.gov ID: NCT05204927

Public ClinicalTrials.gov record NCT05204927. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 10:19 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-Center, Open-Label, Randomized Phase 3 Trial Comparing the Safety and Efficacy of 177Lu-PSMA-I&T Versus Hormone Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A Multi-Center, Open-Label, Randomized Phase 3 Trial Comparing the Safety and Efficacy of 177Lu-PSMA-I\&T versus Hormone Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer.

Study identification

NCT ID
NCT05204927
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Curium US LLC
Industry
Enrollment
439 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 14, 2022 (Actual)
Primary completion
Aug 2, 2024 (Actual)
Completion
Feb 2029 (Estimated)
Last update posted
Sep 4, 2026

2022 – 2029

United States locations

U.S. sites
37
U.S. states
17
U.S. cities
31
Facility City State ZIP Site status
Arizona Institute of Urology, PPLC Tucson Arizona 85704 —
Providence Medical Foundation Fullerton California 92835 —
Long Beach Memorial Center Long Beach California 90806 —
Hoag Memorial Hospital Presbyterian Newport Beach California 92663 —
San Francisco VA Health Care System San Francisco California 94121 —
University of California, San Francisco San Francisco California 94158 —
Providence Saint John's Health Center Santa Monica California 90404 —
GenesisCare USA Boca Raton Florida 33431 —
Biogenix Molecular LLC Miami Florida 33165 —
Orlando Health Cancer Institute Orlando Florida 32806 —
GenesisCare USA Plantation Florida 33324 —
Florida Urology Partners, LLP Tampa Florida 33607 —
Northwestern Memorial Hospital Chicago Illinois 60611 —
NorthShore University HealthSystem-Evanston Hospital Evanston Illinois 60201 —
John Hopkins Hospital Baltimore Maryland 21287 —
Kaiser Permanente Gaithersburg Medical Center Gaithersburg Maryland 20879 —
Henry Ford Hospital Detroit Michigan 48202 —
BAMF Health I PC Grand Rapids Michigan 49503 —
Michigan Institute of Urology Troy Michigan 48084 —
GenesisCare USA Troy Michigan 48098 —
M Health Fairview Ridges Cancer Clinic Burnsville Minnesota 55337 —
SSM Saint Louis University Hospital St Louis Missouri 63104 —
Center for Clinical Theranostics Research, Washington University St Louis Missouri 63110 —
Oncology Hematology West, PC dba Nebraska Cancer Specialists Omaha Nebraska 68130 —
XCancer Omaha / Urology Cancer Center Omaha Nebraska 68130 —
Rutgers Cancer Institute of New Jersey New Brunswick New Jersey 08993 —
Icahn School of Medicine at Mount Sinai New York New York 10029 —
Columbia University Medical Center - Herbert Irving Pavilion New York New York 10032 —
SUNY Upstate Medical University Syracuse New York 13210 —
Central Ohio Urology Group Gahanna Ohio 43230 —
Hightower Clinical Oklahoma City Oklahoma 73102 —
OHSU - Center for health and healing Portland Oregon 97239 —
VA Portland Health Care System Portland Oregon 97239 —
MidLantic Urology Bala-Cynwyd Pennsylvania 19004 —
Houston Metro Urology Houston Texas 77027 —
Urology San Antonio San Antonio Texas 78229 —
Fred Hutchinson Cancer Center Seattle Washington 98109 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 15 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05204927, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 4, 2026 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05204927 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →